Piramal Pharma Ltd

Common Name
Piramal Pharma
Country
India
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
5,476
Ticker
PPLPHARMA
Exchange
NATIONAL STOCK EXCHANGE OF INDIA
Description
Piramal Pharma Ltd. is a leading pharmaceutical company engaged in the development, manufacture, and distribution of a wide range of pharmaceutical products. The company plays a crucial role in the he...

Piramal Pharma's GHG Emissions Data Preview

In 2023, Piramal Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Piramal Pharma has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Piramal Pharma's GHG Emissions data for free

Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.

Verified Sources Behind Piramal Pharma’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Piramal Pharma’s data sources below and access millions more through our Disclosure Search.

a. Piramal Pharma's Sustainability Report 2023
Trace every data point back to Piramal Pharma’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Insights into Piramal Pharma's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Piramal Pharma amounted to 124,249 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2022, the total operational greenhouse gas (GHG) emissions of Piramal Pharma decreased by 8.65%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a

Piramal Pharma's Scope 1 Emissions Over Time

202120222023015 k30 k45 k60 ktCO2e+12%-6%
  • Total Scope 1
  • Year-over-Year Change

What are Piramal Pharma's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Piramal Pharma were 43,277 metric tons of CO₂ equivalent (tCO₂e). a

Has Piramal Pharma reduced its Scope 1 emissions over time?

Since 2021, Piramal Pharma's Scope 1 emissions have increased by 4.54%, reflecting a rising long-term trend in Scope 1 emissions over time. a

Compared to the previous year (2022), Piramal Pharma's Scope 1 emissions decreased by 6.43%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a

What are Piramal Pharma's Scope 2 emissions?

In 2023, Piramal Pharma reported Scope 2 greenhouse gas (GHG) emissions of 80,972 tCO₂e without specifying the calculation method. a

Has Piramal Pharma reduced its Scope 2 emissions over time?

Since 2021, Piramal Pharma's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Piramal Pharma 's emissions have plateaued with no significant change in its energy consumption footprint. a

Compared to the previous year (2022), Piramal Pharma's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Piramal Pharma 's emissions have plateaued with no significant change in its energy consumption footprint. a

What methodology does Piramal Pharma use for Scope 2 reporting?

In 2023, Piramal Pharma reported its Scope 2 emissions using an unspecified methodology. a

Piramal Pharma's Scope 2 Emissions Over Time

202120222023025 k50 k75 k100 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)
Want Full Access to Piramal Pharma's GHG Emissions Dataset?
Sign Up